[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Type 1 Diabetes (T1D) Industry Research Report, Competitive Landscape, Market Size, Regional Status and Prospect

January 2024 | 107 pages | ID: G64AEB976535EN
Maia Research

US$ 3,250.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report combines extensive quantitative analysis and exhaustive qualitative analysis, ranges from a macro overview of the total market size, industry chain, and market dynamics to micro details of segment markets by type, application and region, and, as a result, provides a holistic view of, as well as a deep insight into the Type 1 Diabetes (T1D) market covering all its essential aspects.

For the competitive landscape, the report also introduces players in the industry from the perspective of the market share, concentration ratio, etc., and describes the leading companies in detail, with which the readers can get a better idea of their competitors and acquire an in-depth understanding of the competitive situation. Further, mergers & acquisitions, emerging market trends, the impact of COVID-19, and regional conflicts will all be considered.

In a nutshell, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the market in any manner.

Key players in the global Type 1 Diabetes (T1D) market are covered in Chapter 9:

Samsung Bioepis

Biocon

Eli Lilly

Astellas

Bristol-Myers Squibb

Merck

Boehringer Ingelheim

Lexicon

Novo Nordisk

Janssen

Sanofi

In Chapter 5 and Chapter 7.3, based on types, the Type 1 Diabetes (T1D) market from 2017 to 2027 is primarily split into:

Rapid Acting Insulin Analogs

Long Acting Insulin Analogs

Premix Insulin Analogs

In Chapter 6 and Chapter 7.4, based on applications, the Type 1 Diabetes (T1D) market from 2017 to 2027 covers:

Children

Adults

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historical data and forecast (2017-2027) of the following regions are covered in Chapter 4 and Chapter 7:

United States

Europe

China

Japan

India

Southeast Asia

Latin America

Middle East and Africa

Client Focus

1. Does this report consider the impact of COVID-19 and the Russia-Ukraine war on the Type 1 Diabetes (T1D) market?

Yes. As the COVID-19 and the Russia-Ukraine war are profoundly affecting the global supply chain relationship and raw material price system, we have definitely taken them into consideration throughout the research, and in Chapters 1.7, 2.7, 4.X.1, 7.5, 8.7, we elaborate at full length on the impact of the pandemic and the war on the Type 1 Diabetes (T1D) Industry.

2. How do you determine the list of the key players included in the report?

With the aim of clearly revealing the competitive situation of the industry, we concretely analyze not only the leading enterprises that have a voice on a global scale, but also the regional small and medium-sized companies that play key roles and have plenty of potential growth.

Please find the key player list in Summary.

3. What are your main data sources?

Both Primary and Secondary data sources are being used while compiling the report.

Primary sources include extensive interviews of key opinion leaders and industry experts (such as experienced front-line staff, directors, CEOs, and marketing executives), downstream distributors, as well as end-users.

Secondary sources include the research of the annual and financial reports of the top companies, public files, new journals, etc. We also cooperate with some third-party databases.

Please find a more complete list of data sources in Chapters 11.2.1 & 11.2.2.

4. Can I modify the scope of the report and customize it to suit my requirements?

Yes. Customized requirements of multi-dimensional, deep-level and high-quality can help our customers precisely grasp market opportunities, effortlessly confront market challenges, properly formulate market strategies and act promptly, thus to win them sufficient time and space for market competition.

Outline

Chapter 1 mainly defines the market scope and introduces the macro overview of the industry, with an executive summary of different market segments ((by type, application, region, etc.), including the definition, market size, and trend of each market segment.

Chapter 2 provides a qualitative analysis of the current status and future trends of the market. Industry Entry Barriers, market drivers, market challenges, emerging markets, consumer preference analysis, together with the impact of the COVID-19 outbreak will all be thoroughly explained.

Chapter 3 analyzes the current competitive situation of the market by providing data regarding the players, including their sales volume and revenue with corresponding market shares, price and gross margin. In addition, information about market concentration ratio, mergers, acquisitions, and expansion plans will also be covered.

Chapter 4 focuses on the regional market, presenting detailed data (i.e., sales volume, revenue, price, gross margin) of the most representative regions and countries in the world.

Chapter 5 provides the analysis of various market segments according to product types, covering sales volume, revenue along with market share and growth rate, plus the price analysis of each type.

Chapter 6 shows the breakdown data of different applications, including the consumption and revenue with market share and growth rate, with the aim of helping the readers to take a close-up look at the downstream market.

Chapter 7 provides a combination of quantitative and qualitative analyses of the market size and development trends in the next five years. The forecast information of the whole, as well as the breakdown market, offers the readers a chance to look into the future of the industry.

Chapter 8 is the analysis of the whole market industrial chain, covering key raw materials suppliers and price analysis, manufacturing cost structure analysis, alternative product analysis, also providing information on major distributors, downstream buyers, and the impact of COVID-19 pandemic.

Chapter 9 shares a list of the key players in the market, together with their basic information, product profiles, market performance (i.e., sales volume, price, revenue, gross margin), recent development, SWOT analysis, etc.

Chapter 10 is the conclusion of the report which helps the readers to sum up the main findings and points.

Chapter 11 introduces the market research methods and data sources.

Years considered for this report:

Historical Years: 2017-2021

Base Year: 2021

Estimated Year: 2022

Forecast Period: 2022-2027
1 TYPE 1 DIABETES (T1D) MARKET OVERVIEW

1.1 Product Overview and Scope of Type 1 Diabetes (T1D) Market
1.2 Type 1 Diabetes (T1D) Market Segment by Type
  1.2.1 Global Type 1 Diabetes (T1D) Market Sales Volume and CAGR (%) Comparison by Type (2017-2027)
1.3 Global Type 1 Diabetes (T1D) Market Segment by Application
  1.3.1 Type 1 Diabetes (T1D) Market Consumption (Sales Volume) Comparison by Application (2017-2027)
1.4 Global Type 1 Diabetes (T1D) Market, Region Wise (2017-2027)
  1.4.1 Global Type 1 Diabetes (T1D) Market Size (Revenue) and CAGR (%) Comparison by Region (2017-2027)
  1.4.2 United States Type 1 Diabetes (T1D) Market Status and Prospect (2017-2027)
  1.4.3 Europe Type 1 Diabetes (T1D) Market Status and Prospect (2017-2027)
  1.4.4 China Type 1 Diabetes (T1D) Market Status and Prospect (2017-2027)
  1.4.5 Japan Type 1 Diabetes (T1D) Market Status and Prospect (2017-2027)
  1.4.6 India Type 1 Diabetes (T1D) Market Status and Prospect (2017-2027)
  1.4.7 Southeast Asia Type 1 Diabetes (T1D) Market Status and Prospect (2017-2027)
  1.4.8 Latin America Type 1 Diabetes (T1D) Market Status and Prospect (2017-2027)
  1.4.9 Middle East and Africa Type 1 Diabetes (T1D) Market Status and Prospect (2017-2027)
1.5 Global Market Size of Type 1 Diabetes (T1D) (2017-2027)
  1.5.1 Global Type 1 Diabetes (T1D) Market Revenue Status and Outlook (2017-2027)
  1.5.2 Global Type 1 Diabetes (T1D) Market Sales Volume Status and Outlook (2017-2027)
1.6 Global Macroeconomic Analysis
1.7 The impact of the Russia-Ukraine war on the Type 1 Diabetes (T1D) Market

2 INDUSTRY OUTLOOK

2.1 Type 1 Diabetes (T1D) Industry Technology Status and Trends
2.2 Industry Entry Barriers
  2.2.1 Analysis of Financial Barriers
  2.2.2 Analysis of Technical Barriers
  2.2.3 Analysis of Talent Barriers
  2.2.4 Analysis of Brand Barrier
2.3 Type 1 Diabetes (T1D) Market Drivers Analysis
2.4 Type 1 Diabetes (T1D) Market Challenges Analysis
2.5 Emerging Market Trends
2.6 Consumer Preference Analysis
2.7 Type 1 Diabetes (T1D) Industry Development Trends under COVID-19 Outbreak
  2.7.1 Global COVID-19 Status Overview
  2.7.2 Influence of COVID-19 Outbreak on Type 1 Diabetes (T1D) Industry Development

3 GLOBAL TYPE 1 DIABETES (T1D) MARKET LANDSCAPE BY PLAYER

3.1 Global Type 1 Diabetes (T1D) Sales Volume and Share by Player (2017-2022)
3.2 Global Type 1 Diabetes (T1D) Revenue and Market Share by Player (2017-2022)
3.3 Global Type 1 Diabetes (T1D) Average Price by Player (2017-2022)
3.4 Global Type 1 Diabetes (T1D) Gross Margin by Player (2017-2022)
3.5 Type 1 Diabetes (T1D) Market Competitive Situation and Trends
  3.5.1 Type 1 Diabetes (T1D) Market Concentration Rate
  3.5.2 Type 1 Diabetes (T1D) Market Share of Top 3 and Top 6 Players
  3.5.3 Mergers & Acquisitions, Expansion

4 GLOBAL TYPE 1 DIABETES (T1D) SALES VOLUME AND REVENUE REGION WISE (2017-2022)

4.1 Global Type 1 Diabetes (T1D) Sales Volume and Market Share, Region Wise (2017-2022)
4.2 Global Type 1 Diabetes (T1D) Revenue and Market Share, Region Wise (2017-2022)
4.3 Global Type 1 Diabetes (T1D) Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4 United States Type 1 Diabetes (T1D) Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.4.1 United States Type 1 Diabetes (T1D) Market Under COVID-19
4.5 Europe Type 1 Diabetes (T1D) Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.5.1 Europe Type 1 Diabetes (T1D) Market Under COVID-19
4.6 China Type 1 Diabetes (T1D) Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.6.1 China Type 1 Diabetes (T1D) Market Under COVID-19
4.7 Japan Type 1 Diabetes (T1D) Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.7.1 Japan Type 1 Diabetes (T1D) Market Under COVID-19
4.8 India Type 1 Diabetes (T1D) Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.8.1 India Type 1 Diabetes (T1D) Market Under COVID-19
4.9 Southeast Asia Type 1 Diabetes (T1D) Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.9.1 Southeast Asia Type 1 Diabetes (T1D) Market Under COVID-19
4.10 Latin America Type 1 Diabetes (T1D) Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.10.1 Latin America Type 1 Diabetes (T1D) Market Under COVID-19
4.11 Middle East and Africa Type 1 Diabetes (T1D) Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.11.1 Middle East and Africa Type 1 Diabetes (T1D) Market Under COVID-19

5 GLOBAL TYPE 1 DIABETES (T1D) SALES VOLUME, REVENUE, PRICE TREND BY TYPE

5.1 Global Type 1 Diabetes (T1D) Sales Volume and Market Share by Type (2017-2022)
5.2 Global Type 1 Diabetes (T1D) Revenue and Market Share by Type (2017-2022)
5.3 Global Type 1 Diabetes (T1D) Price by Type (2017-2022)
5.4 Global Type 1 Diabetes (T1D) Sales Volume, Revenue and Growth Rate by Type (2017-2022)
  5.4.1 Global Type 1 Diabetes (T1D) Sales Volume, Revenue and Growth Rate of Rapid Acting Insulin Analogs (2017-2022)
  5.4.2 Global Type 1 Diabetes (T1D) Sales Volume, Revenue and Growth Rate of Long Acting Insulin Analogs (2017-2022)
  5.4.3 Global Type 1 Diabetes (T1D) Sales Volume, Revenue and Growth Rate of Premix Insulin Analogs (2017-2022)

6 GLOBAL TYPE 1 DIABETES (T1D) MARKET ANALYSIS BY APPLICATION

6.1 Global Type 1 Diabetes (T1D) Consumption and Market Share by Application (2017-2022)
6.2 Global Type 1 Diabetes (T1D) Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Type 1 Diabetes (T1D) Consumption and Growth Rate by Application (2017-2022)
  6.3.1 Global Type 1 Diabetes (T1D) Consumption and Growth Rate of Children (2017-2022)
  6.3.2 Global Type 1 Diabetes (T1D) Consumption and Growth Rate of Adults (2017-2022)

7 GLOBAL TYPE 1 DIABETES (T1D) MARKET FORECAST (2022-2027)

7.1 Global Type 1 Diabetes (T1D) Sales Volume, Revenue Forecast (2022-2027)
  7.1.1 Global Type 1 Diabetes (T1D) Sales Volume and Growth Rate Forecast (2022-2027)
  7.1.2 Global Type 1 Diabetes (T1D) Revenue and Growth Rate Forecast (2022-2027)
  7.1.3 Global Type 1 Diabetes (T1D) Price and Trend Forecast (2022-2027)
7.2 Global Type 1 Diabetes (T1D) Sales Volume and Revenue Forecast, Region Wise (2022-2027)
  7.2.1 United States Type 1 Diabetes (T1D) Sales Volume and Revenue Forecast (2022-2027)
  7.2.2 Europe Type 1 Diabetes (T1D) Sales Volume and Revenue Forecast (2022-2027)
  7.2.3 China Type 1 Diabetes (T1D) Sales Volume and Revenue Forecast (2022-2027)
  7.2.4 Japan Type 1 Diabetes (T1D) Sales Volume and Revenue Forecast (2022-2027)
  7.2.5 India Type 1 Diabetes (T1D) Sales Volume and Revenue Forecast (2022-2027)
  7.2.6 Southeast Asia Type 1 Diabetes (T1D) Sales Volume and Revenue Forecast (2022-2027)
  7.2.7 Latin America Type 1 Diabetes (T1D) Sales Volume and Revenue Forecast (2022-2027)
  7.2.8 Middle East and Africa Type 1 Diabetes (T1D) Sales Volume and Revenue Forecast (2022-2027)
7.3 Global Type 1 Diabetes (T1D) Sales Volume, Revenue and Price Forecast by Type (2022-2027)
  7.3.1 Global Type 1 Diabetes (T1D) Revenue and Growth Rate of Rapid Acting Insulin Analogs (2022-2027)
  7.3.2 Global Type 1 Diabetes (T1D) Revenue and Growth Rate of Long Acting Insulin Analogs (2022-2027)
  7.3.3 Global Type 1 Diabetes (T1D) Revenue and Growth Rate of Premix Insulin Analogs (2022-2027)
7.4 Global Type 1 Diabetes (T1D) Consumption Forecast by Application (2022-2027)
  7.4.1 Global Type 1 Diabetes (T1D) Consumption Value and Growth Rate of Children(2022-2027)
  7.4.2 Global Type 1 Diabetes (T1D) Consumption Value and Growth Rate of Adults(2022-2027)
7.5 Type 1 Diabetes (T1D) Market Forecast Under COVID-19

8 TYPE 1 DIABETES (T1D) MARKET UPSTREAM AND DOWNSTREAM ANALYSIS

8.1 Type 1 Diabetes (T1D) Industrial Chain Analysis
8.2 Key Raw Materials Suppliers and Price Analysis
8.3 Manufacturing Cost Structure Analysis
  8.3.1 Labor Cost Analysis
  8.3.2 Energy Costs Analysis
  8.3.3 R&D Costs Analysis
8.4 Alternative Product Analysis
8.5 Major Distributors of Type 1 Diabetes (T1D) Analysis
8.6 Major Downstream Buyers of Type 1 Diabetes (T1D) Analysis
8.7 Impact of COVID-19 and the Russia-Ukraine war on the Upstream and Downstream in the Type 1 Diabetes (T1D) Industry

9 PLAYERS PROFILES

9.1 Samsung Bioepis
  9.1.1 Samsung Bioepis Basic Information, Manufacturing Base, Sales Region and Competitors
  9.1.2 Type 1 Diabetes (T1D) Product Profiles, Application and Specification
  9.1.3 Samsung Bioepis Market Performance (2017-2022)
  9.1.4 Recent Development
  9.1.5 SWOT Analysis
9.2 Biocon
  9.2.1 Biocon Basic Information, Manufacturing Base, Sales Region and Competitors
  9.2.2 Type 1 Diabetes (T1D) Product Profiles, Application and Specification
  9.2.3 Biocon Market Performance (2017-2022)
  9.2.4 Recent Development
  9.2.5 SWOT Analysis
9.3 Eli Lilly
  9.3.1 Eli Lilly Basic Information, Manufacturing Base, Sales Region and Competitors
  9.3.2 Type 1 Diabetes (T1D) Product Profiles, Application and Specification
  9.3.3 Eli Lilly Market Performance (2017-2022)
  9.3.4 Recent Development
  9.3.5 SWOT Analysis
9.4 Astellas
  9.4.1 Astellas Basic Information, Manufacturing Base, Sales Region and Competitors
  9.4.2 Type 1 Diabetes (T1D) Product Profiles, Application and Specification
  9.4.3 Astellas Market Performance (2017-2022)
  9.4.4 Recent Development
  9.4.5 SWOT Analysis
9.5 Bristol-Myers Squibb
  9.5.1 Bristol-Myers Squibb Basic Information, Manufacturing Base, Sales Region and Competitors
  9.5.2 Type 1 Diabetes (T1D) Product Profiles, Application and Specification
  9.5.3 Bristol-Myers Squibb Market Performance (2017-2022)
  9.5.4 Recent Development
  9.5.5 SWOT Analysis
9.6 Merck
  9.6.1 Merck Basic Information, Manufacturing Base, Sales Region and Competitors
  9.6.2 Type 1 Diabetes (T1D) Product Profiles, Application and Specification
  9.6.3 Merck Market Performance (2017-2022)
  9.6.4 Recent Development
  9.6.5 SWOT Analysis
9.7 Boehringer Ingelheim
  9.7.1 Boehringer Ingelheim Basic Information, Manufacturing Base, Sales Region and Competitors
  9.7.2 Type 1 Diabetes (T1D) Product Profiles, Application and Specification
  9.7.3 Boehringer Ingelheim Market Performance (2017-2022)
  9.7.4 Recent Development
  9.7.5 SWOT Analysis
9.8 Lexicon
  9.8.1 Lexicon Basic Information, Manufacturing Base, Sales Region and Competitors
  9.8.2 Type 1 Diabetes (T1D) Product Profiles, Application and Specification
  9.8.3 Lexicon Market Performance (2017-2022)
  9.8.4 Recent Development
  9.8.5 SWOT Analysis
9.9 Novo Nordisk
  9.9.1 Novo Nordisk Basic Information, Manufacturing Base, Sales Region and Competitors
  9.9.2 Type 1 Diabetes (T1D) Product Profiles, Application and Specification
  9.9.3 Novo Nordisk Market Performance (2017-2022)
  9.9.4 Recent Development
  9.9.5 SWOT Analysis
9.10 Janssen
  9.10.1 Janssen Basic Information, Manufacturing Base, Sales Region and Competitors
  9.10.2 Type 1 Diabetes (T1D) Product Profiles, Application and Specification
  9.10.3 Janssen Market Performance (2017-2022)
  9.10.4 Recent Development
  9.10.5 SWOT Analysis
9.11 Sanofi
  9.11.1 Sanofi Basic Information, Manufacturing Base, Sales Region and Competitors
  9.11.2 Type 1 Diabetes (T1D) Product Profiles, Application and Specification
  9.11.3 Sanofi Market Performance (2017-2022)
  9.11.4 Recent Development
  9.11.5 SWOT Analysis

10 RESEARCH FINDINGS AND CONCLUSION


11 APPENDIX

11.1 Methodology
11.2 Research Data Source

LIST OF TABLES AND FIGURES




Figure Type 1 Diabetes (T1D) Product Picture

Table Global Type 1 Diabetes (T1D) Market Sales Volume and CAGR (%) Comparison by Type

Table Type 1 Diabetes (T1D) Market Consumption (Sales Volume) Comparison by Application (2017-2027)

Figure Global Type 1 Diabetes (T1D) Market Size (Revenue, Million USD) and CAGR (%) (2017-2027)

Figure United States Type 1 Diabetes (T1D) Market Revenue (Million USD) and Growth Rate (2017-2027)

Figure Europe Type 1 Diabetes (T1D) Market Revenue (Million USD) and Growth Rate (2017-2027)

Figure China Type 1 Diabetes (T1D) Market Revenue (Million USD) and Growth Rate (2017-2027)

Figure Japan Type 1 Diabetes (T1D) Market Revenue (Million USD) and Growth Rate (2017-2027)

Figure India Type 1 Diabetes (T1D) Market Revenue (Million USD) and Growth Rate (2017-2027)

Figure Southeast Asia Type 1 Diabetes (T1D) Market Revenue (Million USD) and Growth Rate (2017-2027)

Figure Latin America Type 1 Diabetes (T1D) Market Revenue (Million USD) and Growth Rate (2017-2027)

Figure Middle East and Africa Type 1 Diabetes (T1D) Market Revenue (Million USD) and Growth Rate (2017-2027)

Figure Global Type 1 Diabetes (T1D) Market Sales Volume Status and Outlook (2017-2027)

Table Global Macroeconomic Analysis

Figure Global COVID-19 Status Overview

Table Influence of COVID-19 Outbreak on Type 1 Diabetes (T1D) Industry Development

Table Global Type 1 Diabetes (T1D) Sales Volume by Player (2017-2022)

Table Global Type 1 Diabetes (T1D) Sales Volume Share by Player (2017-2022)

Figure Global Type 1 Diabetes (T1D) Sales Volume Share by Player in 2021

Table Type 1 Diabetes (T1D) Revenue (Million USD) by Player (2017-2022)

Table Type 1 Diabetes (T1D) Revenue Market Share by Player (2017-2022)

Table Type 1 Diabetes (T1D) Price by Player (2017-2022)

Table Type 1 Diabetes (T1D) Gross Margin by Player (2017-2022)

Table Mergers & Acquisitions, Expansion Plans

Table Global Type 1 Diabetes (T1D) Sales Volume, Region Wise (2017-2022)

Table Global Type 1 Diabetes (T1D) Sales Volume Market Share, Region Wise (2017-2022)

Figure Global Type 1 Diabetes (T1D) Sales Volume Market Share, Region Wise (2017-2022)

Figure Global Type 1 Diabetes (T1D) Sales Volume Market Share, Region Wise in 2021

Table Global Type 1 Diabetes (T1D) Revenue (Million USD), Region Wise (2017-2022)

Table Global Type 1 Diabetes (T1D) Revenue Market Share, Region Wise (2017-2022)

Figure Global Type 1 Diabetes (T1D) Revenue Market Share, Region Wise (2017-2022)

Figure Global Type 1 Diabetes (T1D) Revenue Market Share, Region Wise in 2021

Table Global Type 1 Diabetes (T1D) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)

Table United States Type 1 Diabetes (T1D) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)

Table Europe Type 1 Diabetes (T1D) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)

Table China Type 1 Diabetes (T1D) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)

Table Japan Type 1 Diabetes (T1D) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)

Table India Type 1 Diabetes (T1D) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)

Table Southeast Asia Type 1 Diabetes (T1D) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)

Table Latin America Type 1 Diabetes (T1D) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)

Table Middle East and Africa Type 1 Diabetes (T1D) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)

Table Global Type 1 Diabetes (T1D) Sales Volume by Type (2017-2022)

Table Global Type 1 Diabetes (T1D) Sales Volume Market Share by Type (2017-2022)

Figure Global Type 1 Diabetes (T1D) Sales Volume Market Share by Type in 2021

Table Global Type 1 Diabetes (T1D) Revenue (Million USD) by Type (2017-2022)

Table Global Type 1 Diabetes (T1D) Revenue Market Share by Type (2017-2022)

Figure Global Type 1 Diabetes (T1D) Revenue Market Share by Type in 2021

Table Type 1 Diabetes (T1D) Price by Type (2017-2022)

Figure Global Type 1 Diabetes (T1D) Sales Volume and Growth Rate of Rapid Acting Insulin Analogs (2017-2022)
Figure Global Type 1 Diabetes (T1D) Revenue (Million USD) and Growth Rate of Rapid Acting Insulin Analogs (2017-2022)
Figure Global Type 1 Diabetes (T1D) Sales Volume and Growth Rate of Long Acting Insulin Analogs (2017-2022)
Figure Global Type 1 Diabetes (T1D) Revenue (Million USD) and Growth Rate of Long Acting Insulin Analogs (2017-2022)
Figure Global Type 1 Diabetes (T1D) Sales Volume and Growth Rate of Premix Insulin Analogs (2017-2022)
Figure Global Type 1 Diabetes (T1D) Revenue (Million USD) and Growth Rate of Premix Insulin Analogs (2017-2022)
Table Global Type 1 Diabetes (T1D) Consumption by Application (2017-2022)

Table Global Type 1 Diabetes (T1D) Consumption Market Share by Application (2017-2022)

Table Global Type 1 Diabetes (T1D) Consumption Revenue (Million USD) by Application (2017-2022)

Table Global Type 1 Diabetes (T1D) Consumption Revenue Market Share by Application (2017-2022)

Table Global Type 1 Diabetes (T1D) Consumption and Growth Rate of Children (2017-2022)
Table Global Type 1 Diabetes (T1D) Consumption and Growth Rate of Adults (2017-2022)
Figure Global Type 1 Diabetes (T1D) Sales Volume and Growth Rate Forecast (2022-2027)

Figure Global Type 1 Diabetes (T1D) Revenue (Million USD) and Growth Rate Forecast (2022-2027)

Figure Global Type 1 Diabetes (T1D) Price and Trend Forecast (2022-2027)

Figure USA Type 1 Diabetes (T1D) Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)

Figure USA Type 1 Diabetes (T1D) Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)

Figure Europe Type 1 Diabetes (T1D) Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)

Figure Europe Type 1 Diabetes (T1D) Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)

Figure China Type 1 Diabetes (T1D) Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)

Figure China Type 1 Diabetes (T1D) Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)

Figure Japan Type 1 Diabetes (T1D) Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)

Figure Japan Type 1 Diabetes (T1D) Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)

Figure India Type 1 Diabetes (T1D) Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)

Figure India Type 1 Diabetes (T1D) Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)

Figure Southeast Asia Type 1 Diabetes (T1D) Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)

Figure Southeast Asia Type 1 Diabetes (T1D) Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)

Figure Latin America Type 1 Diabetes (T1D) Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)

Figure Latin America Type 1 Diabetes (T1D) Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)

Figure Middle East and Africa Type 1 Diabetes (T1D) Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)

Figure Middle East and Africa Type 1 Diabetes (T1D) Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)

Table Global Type 1 Diabetes (T1D) Market Sales Volume Forecast, by Type

Table Global Type 1 Diabetes (T1D) Sales Volume Market Share Forecast, by Type

Table Global Type 1 Diabetes (T1D) Market Revenue (Million USD) Forecast, by Type

Table Global Type 1 Diabetes (T1D) Revenue Market Share Forecast, by Type

Table Global Type 1 Diabetes (T1D) Price Forecast, by Type

Figure Global Type 1 Diabetes (T1D) Revenue (Million USD) and Growth Rate of Rapid Acting Insulin Analogs (2022-2027)
Figure Global Type 1 Diabetes (T1D) Revenue (Million USD) and Growth Rate of Rapid Acting Insulin Analogs (2022-2027)
Figure Global Type 1 Diabetes (T1D) Revenue (Million USD) and Growth Rate of Long Acting Insulin Analogs (2022-2027)
Figure Global Type 1 Diabetes (T1D) Revenue (Million USD) and Growth Rate of Long Acting Insulin Analogs (2022-2027)
Figure Global Type 1 Diabetes (T1D) Revenue (Million USD) and Growth Rate of Premix Insulin Analogs (2022-2027)
Figure Global Type 1 Diabetes (T1D) Revenue (Million USD) and Growth Rate of Premix Insulin Analogs (2022-2027)
Table Global Type 1 Diabetes (T1D) Market Consumption Forecast, by Application

Table Global Type 1 Diabetes (T1D) Consumption Market Share Forecast, by Application

Table Global Type 1 Diabetes (T1D) Market Revenue (Million USD) Forecast, by Application

Table Global Type 1 Diabetes (T1D) Revenue Market Share Forecast, by Application

Figure Global Type 1 Diabetes (T1D) Consumption Value (Million USD) and Growth Rate of Children (2022-2027)
Figure Global Type 1 Diabetes (T1D) Consumption Value (Million USD) and Growth Rate of Adults (2022-2027)
Figure Type 1 Diabetes (T1D) Industrial Chain Analysis

Table Key Raw Materials Suppliers and Price Analysis

Figure Manufacturing Cost Structure Analysis

Table Alternative Product Analysis

Table Downstream Distributors

Table Downstream Buyers

Table Samsung Bioepis Profile
Table Samsung Bioepis Type 1 Diabetes (T1D) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Samsung Bioepis Type 1 Diabetes (T1D) Sales Volume and Growth Rate
Figure Samsung Bioepis Revenue (Million USD) Market Share 2017-2022
Table Biocon Profile
Table Biocon Type 1 Diabetes (T1D) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Biocon Type 1 Diabetes (T1D) Sales Volume and Growth Rate
Figure Biocon Revenue (Million USD) Market Share 2017-2022
Table Eli Lilly Profile
Table Eli Lilly Type 1 Diabetes (T1D) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Eli Lilly Type 1 Diabetes (T1D) Sales Volume and Growth Rate
Figure Eli Lilly Revenue (Million USD) Market Share 2017-2022
Table Astellas Profile
Table Astellas Type 1 Diabetes (T1D) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Astellas Type 1 Diabetes (T1D) Sales Volume and Growth Rate
Figure Astellas Revenue (Million USD) Market Share 2017-2022
Table Bristol-Myers Squibb Profile
Table Bristol-Myers Squibb Type 1 Diabetes (T1D) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Bristol-Myers Squibb Type 1 Diabetes (T1D) Sales Volume and Growth Rate
Figure Bristol-Myers Squibb Revenue (Million USD) Market Share 2017-2022
Table Merck Profile
Table Merck Type 1 Diabetes (T1D) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Merck Type 1 Diabetes (T1D) Sales Volume and Growth Rate
Figure Merck Revenue (Million USD) Market Share 2017-2022
Table Boehringer Ingelheim Profile
Table Boehringer Ingelheim Type 1 Diabetes (T1D) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Boehringer Ingelheim Type 1 Diabetes (T1D) Sales Volume and Growth Rate
Figure Boehringer Ingelheim Revenue (Million USD) Market Share 2017-2022
Table Lexicon Profile
Table Lexicon Type 1 Diabetes (T1D) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Lexicon Type 1 Diabetes (T1D) Sales Volume and Growth Rate
Figure Lexicon Revenue (Million USD) Market Share 2017-2022
Table Novo Nordisk Profile
Table Novo Nordisk Type 1 Diabetes (T1D) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Novo Nordisk Type 1 Diabetes (T1D) Sales Volume and Growth Rate
Figure Novo Nordisk Revenue (Million USD) Market Share 2017-2022
Table Janssen Profile
Table Janssen Type 1 Diabetes (T1D) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Janssen Type 1 Diabetes (T1D) Sales Volume and Growth Rate
Figure Janssen Revenue (Million USD) Market Share 2017-2022
Table Sanofi Profile
Table Sanofi Type 1 Diabetes (T1D) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Sanofi Type 1 Diabetes (T1D) Sales Volume and Growth Rate
Figure Sanofi Revenue (Million USD) Market Share 2017-2022






More Publications